Pharmos preclinical data

PARS (Alachua, Fla.) presented animal data at the International Conference on Stroke in Prague, showing protective effects in rats.

Temporary forebrain ischemia was followed by intravenous injection of the agent, which improved neurological outcome three days after the injury, compared to controls. Infarct size and brain swelling were reduced. ...